The head of Astrazeneca Pharmaceuticals Co., Ltd. has changed last month, with Meng Yihua replacing Wang Lei

On November 4th, reporters noted that the National Enterprise Credit Information Publicity System showed a change in the responsible person of AstraZeneca Pharmaceuticals Co., Ltd., from Wang Lei to MAQDOSI EWA, with the change date being October 11, 2024. On the same day, there were also changes in the market entity type and investors of AstraZeneca Pharmaceuticals Co., Ltd. The market entity type changed from a limited liability company to a limited liability company. The investors changed from Wuxi Xinfang Group Co., Ltd., Jiangsu Wuxi Pharmaceutical Co., Ltd., and AstraZeneca Continent B.V. to AstraZeneca Continent B.V. On October 30th, AstraZeneca's global and China websites announced that Wang Lei, Global Executive Vice President, Chairman of International Business, and President of China, is cooperating with investigations in China